Curis, Inc. (NASDAQ: CRIS) today announced that a medicinal chemistry paper related to the discovery of CUDC-101, Curis's HDAC, EGFR ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE